Downregulation of the ornithine decarboxylase/polyamine system inhibits angiotensin-induced hypertrophy of cardiomyocytes through the NO/cGMP-dependent …

Y Lin, JC Liu, XJ Zhang, GW Li, LN Wang… - Cellular Physiology and …, 2010 - karger.com
Background: Polyamines and nitric oxide (NO) have been involved in the pathogenesis of
cardiac hypertrophy. NO can regulate cardiac ion channels by direct actions on G-proteins …

Polyamine metabolism and the hypertrophic heart

LM Shantz, E Giordano - Polyamine Cell Signaling: Physiology …, 2006 - Springer
Cardiac muscle hypertrophy is one of the most important compensatory responses of the
heart to multiple stresses that may be placed on it. If the stress is not relieved, sustained …

Regulation of ornithine decarboxylase activity in the developing heart of euthyroid or hyperthyroid rats

C LAU, TA SLOTKIN - Molecular Pharmacology, 1980 - ASPET
Ornithine decarboxylase (ODC), the rate-limiting enzyme in the biosynthesis of polyamines,
displays high activity early in postnatal development of the heart, followed by a gradual …

Studies of noradrenergic influence on cardiac ornithine decarboxylase in rats

RW Fuller, SK Hemrick - Journal of Molecular and Cellular Cardiology, 1978 - Elsevier
Ornithine decarboxylase activity in rat heart was increased significantly by the injection of l-
norepinephrine or nisoxetine, an inhibitor of norepinephrine uptake. The enzyme was also …

L-Arginine at the crossroads of biochemical pathways involved in myocardial hypertrophy

E Giordano, LM Shantz, RA Hillary, C Guarnieri… - Signal Transduction and …, 2003 - Springer
Both ornithine decarboxylase (ODC) and nitric oxide synthase (NOS) activities rely on the
availability of the common substrate L-arginine, which is directly processed by NOS to nitric …

Role of polyamines in isoproterenol-induced cardiac hypertrophy: effects of α-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase

JV Bartolome, PA Trepanier, EA Chait… - Journal of Molecular and …, 1982 - Elsevier
DFMO is a selective irreversible inhibitor of ornithine decarboxylase (ODC), the initial
enzyme in the polyamine biosynthetic pathway. DFMO was utilized to determine the role of …

[HTML][HTML] Endoplasmic reticulum stress is involved in DFMO attenuating isoproterenol-induced cardiac hypertrophy in rats

Y Lin, X Zhang, W Xiao, B Li, J Wang, L Jin… - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Studies performed in experimental animals have shown that polyamines
contribute to several physiological and pathological processes, including cardiac …

Involvement of the ornithine decarboxylase/polyamine system in precondition-induced cardioprotection through an interaction with PKC in rat hearts

YJ Zhao, WH Zhang, CQ Xu, HZ Li, LN Wang… - Molecular and cellular …, 2009 - Springer
Polyamines (putrescine, spermidine, and spermine) play an essential role in cell growth,
differentiation, and apoptosis. Protein kinase C (PKC) stimulates polyamine biosynthesis …

Ornithine decarboxylase in cardiac hypertrophy in the rat

S Matsushita, RK Sogani, MS Raben - Circulation Research, 1972 - Am Heart Assoc
Ornithine decarboxylase, a possible rate-limiting enzyme in the synthesis of polyamines,
was assayed in hearts of normal rats, sham-operated rats, and rats subjected to aortic …

Stimulation of rat heart ornithine decarboxylase by isoproterenol: evidence for post-translational control of enzyme activity?

C Lau, TA Slotkin - European Journal of Pharmacology, 1982 - Elsevier
The activity of rat heart ornithine decarboxylase (ODC), the enzyme involved in the initial
step of polyamine biosynthesis, was markedly stimulated after isoproterenol treatment …